Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (431-440 of 498) with videos related to

Pageof 50
Sort By:
European Urology Oncology|July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate CancerSoumyajit Roy, Yilun Sun, James A Eastham, et al.
Cancer Genetics|September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
JAMA Network Open|February 9, 2019
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate CancerAmar U Kishan, Audrey Dang, Alan J Katz, et al.
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
Critical Reviews in Oncology/Hematology|January 26, 2025
Future directions in the evaluation and management of newly diagnosed metastatic cancerEric J Lehrer, Chachrit Khunsriraksakul, Sara Garrett, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
JCO Precision Oncology|January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the ProstateWilliam A Hall, Nick Fishbane, Yang Liu, et al.
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Pageof 50

Showing results (431-440 of 498) with videos related to

Sort By:
Pageof 50
European Urology Oncology|July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate CancerSoumyajit Roy, Yilun Sun, James A Eastham, et al.
Cancer Genetics|September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
JAMA Network Open|February 9, 2019
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate CancerAmar U Kishan, Audrey Dang, Alan J Katz, et al.
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
Critical Reviews in Oncology/Hematology|January 26, 2025
Future directions in the evaluation and management of newly diagnosed metastatic cancerEric J Lehrer, Chachrit Khunsriraksakul, Sara Garrett, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
JCO Precision Oncology|January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the ProstateWilliam A Hall, Nick Fishbane, Yang Liu, et al.
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Pageof 50